These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 11593311)

  • 1. Effect of L-arginine, dimercaptosuccinic acid (DMSA) and the association of L-arginine and DMSA on tissue lead mobilization and blood pressure level in plumbism.
    Malvezzi CK; Moreira EG; Vassilieff I; Vassilieff VS; Cordellini S
    Braz J Med Biol Res; 2001 Oct; 34(10):1341-6. PubMed ID: 11593311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lead-induced hypertension. II. Response to sequential infusions of L-arginine, superoxide dismutase, and nitroprusside.
    Ding Y; Vaziri ND; Gonick HC
    Environ Res; 1998 Feb; 76(2):107-13. PubMed ID: 9515065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Succimer treatment and calcium supplementation reduce tissue lead in suckling rats.
    Marija Varnai V; Piasek M; Blanusa M; Matek Sarić M; Juresa D; Kostial K
    J Appl Toxicol; 2004; 24(2):123-8. PubMed ID: 15052607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial role of monoesters of meso-2,3-dimercaptosuccinic acid in the mobilization of lead and recovery of tissue oxidative injury in rats.
    Saxena G; Pathak U; Flora SJ
    Toxicology; 2005 Oct; 214(1-2):39-56. PubMed ID: 16019123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mobilization of lead over the course of DMSA chelation therapy and long-term efficacy.
    Cory-Slechta DA
    J Pharmacol Exp Ther; 1988 Jul; 246(1):84-91. PubMed ID: 2839672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The synergistic hepatoprotective potential of Beta vulgaris juice and 2,3- dimercaptosuccinic acid in lead-intoxicated rats via improving the hepatic oxidative and inflammatory stress.
    Shaban NZ; Abdelrahman SA; El-Kersh MAL; Mogahed FAK; Talaat IM; Habashy NH
    BMC Complement Med Ther; 2020 Sep; 20(1):268. PubMed ID: 32873301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapy for the cardiovascular effects of perinatal lead exposure in young and adult rats.
    Gaspar AF; Cordellini S
    Arq Bras Cardiol; 2014 Sep; 103(3):219-30. PubMed ID: 25076181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of chelation with meso-dimercaptosuccinic acid (DMSA) before and after the appearance of lead-induced neurotoxicity in the rat.
    Gong Z; Evans HL
    Toxicol Appl Pharmacol; 1997 Jun; 144(2):205-14. PubMed ID: 9194404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effect of combined administration of some naturally occurring antioxidants (vitamins) and thiol chelators in the treatment of chronic lead intoxication.
    Flora SJ; Pande M; Mehta A
    Chem Biol Interact; 2003 Jun; 145(3):267-80. PubMed ID: 12732454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ascorbic acid supplementation does not improve efficacy of meso-dimercaptosuccinic acid treatment in lead-exposed suckling rats.
    Varnai VM; Piasek M; Blanusa M; Juresa D; Sarić M; Kostial K
    Pharmacol Toxicol; 2003 Oct; 93(4):180-5. PubMed ID: 14629742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute and longer term effects of meso-2,3 dimercaptosuccinic acid (DMSA) on the behavior of lead-exposed and control mice.
    Stewart PW; Blaine C; Cohen M; Burright RG; Donovick PJ
    Physiol Behav; 1996; 59(4-5):849-55. PubMed ID: 8778876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined chelation therapy in reducing tissue lead concentrations in suckling rats.
    Kostial K; Blanusa M; Piasek M; Restek-Samarzija N; Jones MM; Singh PK
    J Appl Toxicol; 1999; 19(3):143-7. PubMed ID: 10362263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Succimer and the reduction of tissue lead in juvenile monkeys.
    Smith DR; Woolard D; Luck ML; Laughlin NK
    Toxicol Appl Pharmacol; 2000 Aug; 166(3):230-40. PubMed ID: 10906287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of combined administration of captopril and DMSA on arsenite induced oxidative stress and blood and tissue arsenic concentration in rats.
    Kalia K; Narula GD; Kannan GM; Flora SJ
    Comp Biochem Physiol C Toxicol Pharmacol; 2007 Jan; 144(4):372-9. PubMed ID: 17188940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoic acid in combination with a chelator ameliorates lead-induced peroxidative damages in rat kidney.
    Sivaprasad R; Nagaraj M; Varalakshmi P
    Arch Toxicol; 2002 Aug; 76(8):437-41. PubMed ID: 12185410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination and metabolism of dithiol chelating agents. XV. The meso-2,3-dimercaptosuccinic acid-cysteine (1:2) mixed disulfide, a major urinary metabolite of DMSA in the human, increases the urinary excretion of lead in the rat.
    Maiorino RM; Aposhian MM; Xu ZF; Li Y; Polt RL; Aposhian HV
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1221-6. PubMed ID: 8263783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of combined administration of calcium, iron, zinc, chrysanthemum flavonoids, and DMSA on the treatment of lead intoxication in mice.
    Huali T; Honglei P; Feng W; Shaokang W; Ligang Y; Jianghong L; Guiju S
    J Biochem Mol Toxicol; 2020 Feb; 34(2):e22425. PubMed ID: 31729815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual and combined effect of meso-2,3-dimercaptosuccinic acid and allicin on blood and tissue lead content in mice.
    Aslani MR; Najarnezhad V; Mohri M
    Planta Med; 2010 Feb; 76(3):241-4. PubMed ID: 19764011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of chelate treatments on kidney, bone and brain lead levels of lead-intoxicated mice.
    Jones MM; Basinger MA; Gale GR; Atkins LM; Smith AB; Stone A
    Toxicology; 1994 Apr; 89(2):91-100. PubMed ID: 8197593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral succimer decreases the gastrointestinal absorption of lead in juvenile monkeys.
    Cremin JD; Luck ML; Laughlin NK; Smith DR
    Environ Health Perspect; 2001 Jun; 109(6):613-9. PubMed ID: 11445516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.